Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Beattie; David
Address:
Horsham, GB
No. of patents:
8
Patents:












Patent Number Title Of Patent Date Issued
8283362 Beta-2-adrenoreceptor agonists October 9, 2012
Compounds of formula ##STR00001## in free or salt or solvate form, where Ar is a group of formula ##STR00002## Y is carbon or nitrogen and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, X, n, p, q and r are as defined in the specification,
8273900 Organic compounds September 25, 2012
There are described cyclohexyl amide derivatives useful as corticotropin releasing factor (CRF.sub.1) receptor antagonists.
8067437 Beta-2-adrenoreceptor agonists November 29, 2011
Compounds of formula ##STR00001## in free or salt or solvate form, where Ar is a group of formula ##STR00002## Y is carbon or nitrogen and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, X, n, p, q and r are as defined in the specification,
7820694 Beta-2-adrenoreceptor agonists October 26, 2010
Compounds of formula ##STR00001## in free or salt or solvate form, where Ar is a group of formula ##STR00002## Y is carbon or nitrogen and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, X, n, p, q and r are as defined in the specification,
7745462 Quinoline-2-one derivatives for the treatment of airways diseases June 29, 2010
Compounds of formula I ##STR00001## in free or salt form, wherein --C--Y--, R.sup.1 and R.sup.2 are G have the meanings as indicated in the specification, are useful for treating conditions that are prevented or alleviated by activation of the .beta..sub.2-adrenoreceptor. Pharmaceut
7622483 .beta.2-adrenoceptor agonists November 24, 2009
Compounds of formula ##STR00001## in free or salt or solvate form, where Ar is a group of formula ##STR00002## Y is carbon or nitrogen and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, X, n, p, q and r are as defined in the specification,
6921757 Organic compounds July 26, 2005
Compounds of formula (I), where R is a monovalent cyclic organic group having from 3 to 15 atoms in the ring system, useful as pharmaceuticals ##STR1##
6878721 Beta2-adrenoceptor agonists April 12, 2005
Compounds of formula ##STR1##in free or salt or solvate form, where Ar is a group of formula ##STR2##Y is carbon or nitrogen and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8, R.sup.9, R.sup.10, X, n, p, q and r are as defined in the specification, their p










 
 
  Recently Added Patents
Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability
System and methods for random parameter filtering
Communication apparatus, integrated circuit, and communication method
Specializing disambiguation of a natural language expression
Passive translational velocity measurement from optical information
Pattern forming method using developer containing organic solvent and rinsing solution for use in the pattern forming method
Non-disruptive configuration of a virtualization controller in a data storage system
  Randomly Featured Patents
Reset pulse signal generating circuit
Transmitting station for wireless telephone system with diversity transmission and method
Cyclone separator assembly and surface cleaning apparatus having same
Semiconductor device and method of manufacturing thereof
Homeopathic remedies and methods for enhancing weight loss
Method for sharing relationship information stored in a social network database with third party databases
Method of and device for recording information
Integration of a terahertz quantum cascade laser with a hollow waveguide
Apparatus for temperature control of a resistor used for measurement purposes, especially in internal combustion engines
Ultrasound diagnostic apparatus and method of forming an ultrasound image by the apparatus